The Journal of Phytopharmacology, 2020;9(2):149-154 ; DOI:10.31254/phyto.2020.9213
Review on secondary metabolites and therapeutics activities of Acacia nilotica used in African phytomedicine
Okri Frejus Hans Ohouko1,2 , Koffi Koudouvo2 , Jacques Tossou Dougnon1 , Arnaud Sas Soha1 , Jacques Adouko1 , Amegnona Agbonon2 , Messanvi Gbeassor2
1. Research Unit in Applied Microbiology and Pharmacology of Natural Substances (URMAPha), Laboratory of Research in Applied Biology (LARBA), University of Abomey Calavi, 01 BP 2009 Cotonou
2. Centre of Training and Research in Medicinal Plant (CERFOPLAM), Laboratory of Physiology and Pharmacology of Natural Substances, Faculty of Science, University of Lome, BP 1515 Lome, Togo
*Author to whom correspondence should be addressed.
Received: 19th March, 2020 / Accepted: 31st March, 2020
Today, more than 80% of the West African population use traditional medicine in case of illness. However, several research studies are carried out in order to improve animal health, especially about antimicrobial resistance and vaccine failures observed in farms. This study aimed to review findings about second metabolites and therapeutics activities of Acacia nilotica used in African phytomedicine. Information has been searched on databases such as Agora, Hinari, Google Scholar, various journals, books and articles. Information capitalized are about traditional use of A. nilotica, antiviral, antifungal, antiparasitic, antibacterial, antiplasmodial, anti-inflammatory and anti-hypertensive activities of the plant. These notions constituted will help for better management of disease and other research perspectives like in vivo test of Acacia nilotica extracts on viral pathologies in Animal health.
Acacia nilotica, Review, Traditional use, Pharmacological activities.
HOW TO CITE THIS ARTICLE
Ohouko OFH, Koudouvo K, Dougnon JT, Soha AS, Adouko J, Agbonon A et al. Review on secondary metabolites and therapeutics activities of Acacia nilotica used in African phytomedicine. J Phytopharmacol 2020 ; 9 ( 2):149 - 154 .
Creative Commons (CC) License-
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY 4.0) license. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. (http://creativecommons.org/licenses/by/4.0/).
Copyright
Copyright © 2020 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0.